Skip to Content

Fidelity Advisor® Biotechnology A FBTAX

Quantitative rating as of
NAV / 1-Day Return
24.49  /  2.24 %
Total Assets
1.8 Bil
Adj. Expense Ratio
1.000%
Expense Ratio
1.000%
Distribution Fee Level
Low
Share Class Type
Front Load
Category
Health
Investment Style
Mid Growth
Min. Initial Investment
0
Status
Open
TTM Yield
0.39%
Turnover
43%

Morningstar’s Analysis FBTAX

Will FBTAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Summary

|

An upgrade in People Pillar rating is the primary driver of Fidelity Advisor® Biotechnology A's upgrade to a Morningstar Quantitative Rating of Bronze from Neutral. The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Unlock our full analysis with Morningstar Investor